U.S. markets open in 8 hours 15 minutes

Helix BioPharma Corp. (HBP.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.89000.0000 (0.00%)
At close: 3:25PM EST
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close0.8900
Open0.8900
Bid0.8900 x 0
Ask0.9400 x 0
Day's Range0.8900 - 0.9400
52 Week Range0.2500 - 2.0100
Volume23,925
Avg. Volume77,646
Market Cap125.608M
Beta (5Y Monthly)0.00
PE Ratio (TTM)N/A
EPS (TTM)-0.0540
Earnings DateMar 16, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.25
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Helix Biopharma Corp. Responds to Market Activity
      ACCESSWIRE

      Helix Biopharma Corp. Responds to Market Activity

      RICHMOND HILL, ON / ACCESSWIRE / January 13, 2021 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on its proprietary technological platform DOS47, wishes to confirm that it is not aware of any material, undisclosed information related to the Company that would account for the recent increase in the market price and level of trading volume of its ordinary shares.

    • Helix BioPharma Corp. Closes Private Placement
      ACCESSWIRE

      Helix BioPharma Corp. Closes Private Placement

      RICHMOND HILL, ON / ACCESSWIRE / December 30, 2020 / Helix BioPharma Corp.

    • HBP.TO: Private Placement Completed
      Zacks Small Cap Research

      HBP.TO: Private Placement Completed

      By John Vandermosten, CFA TSX:HBP.TO | OTC:HBPCF READ THE FULL HBP.TO RESEARCH REPORT First Quarter Fiscal Year 2021 Operational and Financial Results Helix BioPharma Corp. (TSX: HBP.TO) (OTC:HBPCF) reported first quarter fiscal year 2021 financial and operational results and submitted SEDAR filings on December 15, 2020. During 1Q:21, extending from August 1 to October 31, 2020,